Showing results (601-610 of 3,348) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|June 3, 2009
Cost effectiveness of drug-eluting stents in Belgian practice: healthcare payer perspectiveMattias Neyt, Chris De Laet, Annemieke De Ridder, et al.Pharmacoeconomics|October 15, 2008
A cost-effectiveness analysis of currently approved treatments for HBeAg-positive chronic hepatitis BD Eldon Spackman, David L VeenstraPharmacoeconomics|October 15, 2008
Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost dataAlan G Wade, José-Luis Fernández, Clément François, et al.Pharmacoeconomics|November 19, 2008
Measuring US pharmaceutical industry R&D spendingJoseph Golec, John VernonPharmacoeconomics|November 19, 2008
Management and prevention of diabetic foot ulcers and infections: a health economic reviewIvy Chow, Elkin V Lemos, Thomas R EinarsonPharmacoeconomics|January 19, 2013
The humanistic and economic burden of systemic lupus erythematosus : a systematic reviewRachel Meacock, Nicola Dale, Mark J HarrisonPharmacoeconomics|February 8, 2013
What works and what doesn't work well in the US healthcare systemHarold S LuftPharmacoeconomics|February 8, 2013
Do health-related labour costs weaken the competitiveness of the economy?Bertram Häussler, Thomas Ecker, Markus SchneiderPharmacoeconomics|February 8, 2013
The impact of incremental innovation in biopharmaceuticals: drug utilisation in original and supplemental indicationsErnst R Berndt, Iain M Cockburn, Karen A GrépinPharmacoeconomics|April 16, 2013
Cost effectiveness of targeted high-dose atorvastatin therapy following genotype testing in patients with acute coronary syndromeAnju Parthan, Kevin J Leahy, Amy K O'Sullivan, et al.Pageof 335